The Current Ratio as of December 2025 (TTM) for Corcept Therapeutics Incorporated (CORT) is 3.14

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 3.14. This represents a change of -0.43% compared to the average of 3.15 of the last 4 quarters.

Corcept Therapeutics Incorporated (CORT) Historical Current Ratio (quarterly & annually)

How has CORT Current Ratio performed in the past?

The mean historical Current Ratio of Corcept Therapeutics Incorporated over the last ten years is 14.35. The current 3.14 Current Ratio has changed 2.09% with respect to the historical average. Over the past ten years (40 quarters), CORT's Current Ratio was at its highest in in the December 2021 quarter at 55.21. The Current Ratio was at its lowest in in the June 2016 quarter at 1.77.

Corcept Therapeutics Incorporated (CORT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corcept Therapeutics Incorporated (CORT) Average Current Ratio

How has CORT Current Ratio performed in the past?

The current Current Ratio of Corcept Therapeutics Incorporated (CORT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Corcept Therapeutics Incorporated (CORT) Current Ratio vs. Peers

How is CORT’s Current Ratio compared to its peers?

Corcept Therapeutics Incorporated’s Current Ratio is greater than Halozyme Therapeutics, Inc. (1.59), greater than Abivax S.A. (0.77), less than Rhythm Pharmaceuticals, Inc. (4.75), less than Merus N.V. (7.97), less than Cytokinetics, Incorporated (6.88), greater than Jazz Pharmaceuticals plc (1.65), less than Caris Life Sciences, Inc. (9.93), greater than Axsome Therapeutics, Inc. (1.57), less than Nuvalent, Inc. (10.73), less than Avidity Biosciences, Inc. (9.26),

Build a custom stock screener for Corcept Therapeutics Incorporated (CORT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (CORT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.